📢 Latest Update: UGC Discontinues CARE Journal Listing: New Guidelines for Selecting Peer-Reviewed Journals View Now

[email protected] +91 1204740990
International Journal of Vaccines Cover

International Journal of Vaccines

E-ISSN: 3048-5681 | Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access

About the Journal

International Journal of Vaccines is a peer-reviewed open-access journal launched in 2024 that focuses on the International Journal of Vaccines was on all facets of vaccine research. It explains the complex characteristics of atypical disease symptoms followed by chronic disease development, whose diagnosis results in the discovery of novel aspects or mechanisms in the pathology of that disease boosting the immune system, the body & natural system for combating disease. The International Journal of Vaccines is happy to accept research papers, review articles, case reports, and popular articles. In the field of medicine, it points the way toward the development of novel treatments or processes for the treatment of long-term illnesses. Scientific findings, both theoretical and experimental, should be published in as much detail as possible. The length of the articles is therefore not limited. To enable the replication of the results, all experimental and computational data must be made available.

View full focus & scope More

Journal Information

Title: International Journal of Vaccines
Abbreviation: ijv
Issues Per Year: 2 Issues
E-ISSN: 3048-5681
Publisher: STM Journals
DOI: 10.37591/IJV
Starting Year: 2024
Subject: Vaccines
Publication Format: Hybrid Open Access
Copyright Policy: CC BY-NC-ND
Type: Peer-reviewed Journal (Refereed Journal)

Address:

STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd. A-118, 1st Floor, Sector-63, Noida, U.P. India, Pin - 201301

Editorial Board

View Full Editorial Board

ijv maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Editor in Chief

Editor

Dr. Amit Awasthi, Senior Professor

Translational Health Science & Technology Institute, Haryana, India,

Email :

Latest Articles

Ahead of Print

Advancing Cancer Vaccine Development through CRISPR/Cas9 Technologies and Future Opportunities

The advent of CRISPR/Cas9 genome editing has revolutionized the cancer immunotherapy market, offering unprecedented precision and versatility in the development of next-generation cancer vaccines.

CRISPR/Cas9, Cancer vaccines, Neoantigen discovery, Tumor microenvironment, Precision oncology, Gene delivery systems

Effectiveness of structured teaching programme on knowledge regarding Prophylactic vaccination against cervical cancer among adolescent girls

Adolescent health encompasses the variety of methods used to prevent, identify, or treat the health and wellness of young people.

Cervical cancer, prophylactic vaccination, adolescent girls. HPV Vaccination, Structured Teaching Program (STP).

Perception of Islamic Scholars towards Polio Vaccination in Northern Nigeria

Poliomyelitis, commonly known as polio, is a highly infectious disease that can lead to permanent paralysis and, in severe cases, death.

Islamic scholars, Northern Nigeria, perception, Polio, vaccination.

Toward Comprehensive Immunization: The Role of Combined COVID-19 and Influenza Vaccines in Public Health

The emergence of multi-pathogen vaccines, particularly those combining protection against COVID- 19 and influenza, marks a significant advancement in immunization efforts.

COVID-19, Influenza, Multi-Pathogen Vaccines, mRNA Vaccine Technology, Public Health Immunization.

Practical studies in Vero cell and Human amnion cells for viral and stem cell applications

Vero cells are one of the most popular mammalian continuous cells in molecular, cellular, and microbiological research.

Vero cells, Human amnion cells, Stem cell therapy, Viral replication, Vaccine production.

SiRNA-Based Multivalent Vaccines: A Systematic Review of Potential Risks, Benefits, and Future Applications

Small interfering RNA (siRNA) technology represents a promising innovation in vaccine development, especially for multivalent vaccines that can target multiple pathogens or antigenic variants simultaneously.

Adverse immune reactions, combination therapy, delivery systems, lipid nanoparticles, targeted therapy.